# Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays

> **NCT04289428** · — · WITHDRAWN · sponsor: **Kirby Institute**

## Conditions studied

- Hepatitis B

## Interventions

- **DIAGNOSTIC_TEST:** Xpert® HBV DNA fingerstick point of care assay
- **DIAGNOSTIC_TEST:** Point of Care ALT
- **DIAGNOSTIC_TEST:** Xpert® HBV DNA point of care assay from dried blood spot

## Key facts

- **NCT ID:** NCT04289428
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2022-07
- **Final completion:** 2022-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding not awarded. A new study design and protocol have been submitted
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04289428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04289428, "Evaluation of Novel Point of Care Hepatitis B Diagnostic Assays". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04289428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*